Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

miR‑342 inhibits glioma cell proliferation by targeting GPRC5A.

Wang J, Yang Y, Cao Y, Tang X.

Mol Med Rep. 2019 Jul;20(1):252-260. doi: 10.3892/mmr.2019.10242. Epub 2019 May 15.

PMID:
31115523
2.

Genome-Wide and Phenotypic Evaluation of Stem Cell Progenitors Derived From Gprc5a-Deficient Murine Lung Adenocarcinoma With Somatic Kras Mutations.

Daouk R, Hassane M, Bahmad HF, Sinjab A, Fujimoto J, Abou-Kheir W, Kadara H.

Front Oncol. 2019 Apr 2;9:207. doi: 10.3389/fonc.2019.00207. eCollection 2019.

3.

Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality.

Guo W, Hu M, Wu J, Zhou A, Liao Y, Song H, Xu D, Kuang Y, Wang T, Jing B, Li K, Ling J, Wen D, Wu W.

Biomed Pharmacother. 2019 Jun;114:108791. doi: 10.1016/j.biopha.2019.108791. Epub 2019 Mar 19.

4.

High levels of RAI3 expression is linked to shortened survival in esophageal cancer patients.

El Gammal AT, Melling N, Reeh M, Gebauer F, Mann O, Perez D, Bockhorn M, Bachmann K, Izbicki JR, Grupp K.

Exp Mol Pathol. 2019 Apr;107:51-56. doi: 10.1016/j.yexmp.2019.01.013. Epub 2019 Jan 29.

PMID:
30707896
5.

Clinical significance of reduced GPRC5A expression in surgically resected non-small cell lung cancer.

Jin E, Wang W, Fang M, Wang W, Xie R, Zhou H, Ye J, Xu R, Ma S.

Oncol Lett. 2019 Jan;17(1):502-507. doi: 10.3892/ol.2018.9537. Epub 2018 Oct 2.

6.

circGprc5a Promoted Bladder Oncogenesis and Metastasis through Gprc5a-Targeting Peptide.

Gu C, Zhou N, Wang Z, Li G, Kou Y, Yu S, Feng Y, Chen L, Yang J, Tian F.

Mol Ther Nucleic Acids. 2018 Dec 7;13:633-641. doi: 10.1016/j.omtn.2018.10.008. Epub 2018 Oct 18.

7.

The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.

Klaschik K, Hauke J, Neidhardt G, Tränkle C, Surowy HM, Heilmann-Heimbach S, Rappl G, Mangold E, Arnold N, Niederacher D, Sutter C, Burwinkel B, Engel C, Wappenschmidt B, Meindl A, Ernst C, Weber-Lassalle K, Weber-Lassalle N, Schmidt S, Borde J, Schmutzler RK, Hahnen E, Pohl-Rescigno E.

Int J Cancer. 2019 Apr 1;144(7):1761-1763. doi: 10.1002/ijc.32016. Epub 2019 Jan 6. No abstract available.

PMID:
30474284
8.

Response to: The GPRC5A frameshift variant c.183del is not associated with increased breast cancer risk in BRCA1 mutation carriers.

Bulanova DR, Helenius M, Sokolenko AP, Kuznetsov SG, Imyanitov EN.

Int J Cancer. 2019 Apr 1;144(7):1758-1760. doi: 10.1002/ijc.32013. Epub 2019 Jan 6. No abstract available. Erratum in: Int J Cancer. 2019 Aug 1;145(3):E16.

PMID:
30474109
9.

Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways.

Duffy DL, Zhu G, Li X, Sanna M, Iles MM, Jacobs LC, Evans DM, Yazar S, Beesley J, Law MH, Kraft P, Visconti A, Taylor JC, Liu F, Wright MJ, Henders AK, Bowdler L, Glass D, Ikram MA, Uitterlinden AG, Madden PA, Heath AC, Nelson EC, Green AC, Chanock S, Barrett JH, Brown MA, Hayward NK, MacGregor S, Sturm RA, Hewitt AW; Melanoma GWAS Consortium, Kayser M, Hunter DJ, Newton Bishop JA, Spector TD, Montgomery GW, Mackey DA, Smith GD, Nijsten TE, Bishop DT, Bataille V, Falchi M, Han J, Martin NG.

Nat Commun. 2018 Nov 14;9(1):4774. doi: 10.1038/s41467-018-06649-5. Erratum in: Nat Commun. 2019 Jan 14;10(1):299.

10.

GPRC5A: An Emerging Biomarker in Human Cancer.

Jiang X, Xu X, Wu M, Guan Z, Su X, Chen S, Wang H, Teng L.

Biomed Res Int. 2018 Oct 17;2018:1823726. doi: 10.1155/2018/1823726. eCollection 2018. Review.

11.

Bladder cancer detection by urinary extracellular vesicle mRNA analysis.

Murakami T, Yamamoto CM, Akino T, Tanaka H, Fukuzawa N, Suzuki H, Osawa T, Tsuji T, Seki T, Harada H.

Oncotarget. 2018 Aug 28;9(67):32810-32821. doi: 10.18632/oncotarget.25998. eCollection 2018 Aug 28.

12.

Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis.

Greenhough A, Bagley C, Heesom KJ, Gurevich DB, Gay D, Bond M, Collard TJ, Paraskeva C, Martin P, Sansom OJ, Malik K, Williams AC.

EMBO Mol Med. 2018 Nov;10(11). pii: e8699. doi: 10.15252/emmm.201708699.

13.

GPRC5A deficiency leads to dysregulated MDM2 via activated EGFR signaling for lung tumor development.

Song H, Sun B, Liao Y, Xu D, Guo W, Wang T, Jing B, Hu M, Li K, Yao F, Deng J.

Int J Cancer. 2019 Feb 15;144(4):777-787. doi: 10.1002/ijc.31726. Epub 2018 Oct 26.

PMID:
29992578
14.

The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer.

Liu B, Yang H, Pilarsky C, Weber GF.

Int J Mol Sci. 2018 Jun 26;19(7). pii: E1870. doi: 10.3390/ijms19071870.

15.

GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets.

Insel PA, Sriram K, Wiley SZ, Wilderman A, Katakia T, McCann T, Yokouchi H, Zhang L, Corriden R, Liu D, Feigin ME, French RP, Lowy AM, Murray F.

Front Pharmacol. 2018 May 22;9:431. doi: 10.3389/fphar.2018.00431. eCollection 2018.

16.

Depletion of Gprc5a Promotes Development of Diabetic Nephropathy.

Ma X, Schwarz A, Sevilla SZ, Levin A, Hultenby K, Wernerson A, Lal M, Patrakka J.

J Am Soc Nephrol. 2018 Jun;29(6):1679-1689. doi: 10.1681/ASN.2017101135. Epub 2018 Apr 10.

17.

Genome-Wide Gene Expression Changes in the Normal-Appearing Airway during the Evolution of Smoking-Associated Lung Adenocarcinoma.

Kantrowitz J, Sinjab A, Xu L, McDowell TL, Sivakumar S, Lang W, Nunomura-Nakamura S, Fukuoka J, Nemer G, Darwiche N, Chami H, Tfayli A, Wistuba II, Scheet P, Fujimoto J, Spira AE, Kadara H.

Cancer Prev Res (Phila). 2018 Apr;11(4):237-248. doi: 10.1158/1940-6207.CAPR-17-0295. Epub 2018 Jan 30.

18.

Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A.

Shrestha S, Yang CD, Hong HC, Chou CH, Tai CS, Chiew MY, Chen WL, Weng SL, Chen CC, Chang YA, Lee ML, Huang WY, Hsu SD, Chen YC, Huang HD.

Int J Mol Sci. 2017 Dec 28;19(1). pii: E87. doi: 10.3390/ijms19010087.

19.

Whole-exome sequencing to identify novel mutations of nevoid basal cell carcinoma syndrome in a Chinese population.

Lu N, Wang J, Zhu B, Zhang M, Qi F, Wang X, Gu J.

Cancer Biomark. 2017 Dec 12;21(1):161-168. doi: 10.3233/CBM-170541.

PMID:
29081410
20.

RAI3 knockdown promotes adipogenic differentiation of human adipose-derived stem cells by decreasing β-catenin levels.

Jin C, Wang W, Liu Y, Zhou Y.

Biochem Biophys Res Commun. 2017 Nov 4;493(1):618-624. doi: 10.1016/j.bbrc.2017.08.142. Epub 2017 Sep 1.

PMID:
28870805

Supplemental Content

Loading ...
Support Center